Do you want to read an article? Please log in or register.
First experience in Switzerland in Phe508del homozygous cystic fibrosis patients with end-stage pulmonary disease enrolled in a lumacaftor-ivacaftor therapy trial - preliminary results
![](https://cdn.healthbook.network/wp-content/uploads/2018/03/like_hb.png)